Cargando…
Association of metabolic‐associated fatty liver disease and risk of severe coronavirus disease 2019 illness
Given the global health burden caused by the Coronavirus Disease 2019 (COVID‐19), there have been numerous studies aimed to understand its clinical course and to determine risk factors that may impact prognosis. Pre‐existing medical conditions are linked with COVID‐19 severity, particularly cardiome...
Autores principales: | Sy‐Janairo, Marianne Linley, Y Cua, Ian Homer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753749/ https://www.ncbi.nlm.nih.gov/pubmed/33363258 http://dx.doi.org/10.1002/jgh3.12465 |
Ejemplares similares
-
Data on the sequence-derived properties of gastric cancer – binding peptides
por: Janairo, Jose Isagani B., et al.
Publicado: (2020) -
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021) -
Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021) -
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
por: Xu, Yanlan, et al.
Publicado: (2021) -
COVID‐19 and its effects on the digestive system and endoscopy practice
por: Aguila, Enrik John T., et al.
Publicado: (2020)